Schedule 8

EIGHTH SCHEDULERegulations 2(1) and 13E(2)First column Second column Third columnHigh‑cost drug treatment for specified clinical indication Operative date for treatment received Maximum amount that may be withdrawn1.Treatment and prophylaxis for haemophilia A With effect from 1 October 2025 $140 per month2.Treatment and prophylaxis for haemophilia B With effect from 1 October 2025 $480 per month3.Treatment for immune thrombocytopenia or refractory severe aplastic anaemia With effect from 1 October 2025 $180 per month4.Treatment for thalassaemia With effect from 1 October 2025 $80 per month5.Treatment for conditions associated with growth failure in children with short stature With effect from 1 October 2025 $80 per month6.Treatment for spinal muscular atrophy With effect from 1 October 2025 $740 per month7.Treatment for Fabry disease With effect from 1 October 2025 $440 per month8.Treatment for X‑linked hypophosphataemia With effect from 1 October 2025 $680 per month